President Barack Obama on Friday said his administration will grant a broader exemption for religious organization that have an objection to providing contraceptive services to women as part of their health plans. The announcement comes amid a brewing controversy over his administration's proposal to grant a much narrower exemption.
Among California's burgeoning Middle Eastern population, not everything is well. Many of the newest immigrants, refugees, suffering from post-traumatic stress disorder. But cultural stereotypes make them loath to get the help they need.
Despite its position as a leading cause of death and debilitating disease afflicting many Americans, funding for research on Alzheimer's is sparse. Critics say that's hurting efforts to find a cure.
The FDA had been making plans to allow TEVA Pharmaceuticals to sell its Plan B contraceptive in front of the pharmacy counter to women of any age. But Health and Human Services Secretary Kathleen Sebelius intervened at the last minute to prevent it.
Drug makers 50 years ago finally removed the drug thalidomide from the market as evidence mounted that it caused terrible birth defects, especially in Europe. But for an alert, determined FDA employee, it could have been as bad or worse in the United States.
An 8-year-old Ohio boy was taken from his parents and his home because he's overweight. He weighs nearly 200 pounds when a typical third grader weighs 60 pounds. Now the state has put him in foster care, but many are wondering if it's going to help — and if it's even right.
Romania's public healthcare system is under fire for being woefully inadequate. According to many, the poor will wait years for even basic services, doctors are leaving the profession or going overseas to practice medicine.
With Mitt Romney the only GOP presidential candidate with staying power, and with Tea Party activists growing more and more dissatisfied with him, is it possible the situation is ripe for a third party candidate to emerge?
Late last week, the FDA ruled that Avastin could no longer be marketed as treatment for breast cancer. But Medicare and virtually all private insurance providers will continue to pay for just that use of the drug. It's a mixed message that has raised some eyebrows.
The U.S. Supreme Court today announced it would consider whether President Barack Obama's healthcare legislation is constitutional — and they've booked 5.5 hours for the discussion in the spring.